TSHA

Taysha Gene Therapies Inc (TSHA)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 810.2M
P/E Ratio
0.00
Revenue (TTM)
$ 8.1M
Volume
0
52W High
$ 3.31
52W Low
$ 1.05
Dividend Yield
0.00%
Beta
0.96

Technicals

50-Day MA
2.6546
200-Day MA
2.1377
52 Week High
3.31
52 Week Low
1.05

About TSHA

Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of th.

Employees
73
Headquarters
Dallas, TX
CEO
Mr. Sean P. Nolan

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg